Basel, 14 June 2019 – Straumann has decided not to explore a potential scanner collaboration with Align Technology, which was discussed in connection with the patent settlement agreement announced by the two companies in March.
As part of the settlement, which brought to an end a long-standing patent dispute between Align and ClearCorrect, Straumann and Align signed a non-binding Letter of Intent to explore the development and distribution of iTero intraoral scanners made by Align, which would be fully integrated into Straumann’s CARES workflow. Straumann committed to pay Align an additional USD 16 million, if the companies failed to enter into the potential development and distribution agreement. Accounting for this and a settlement consideration in the ClearCorrect acquisition agreement, the Group expects a one-time exceptional expense of CHF 24 million in its 2019 H1 results – as previously communicated in April.
Straumann will continue to build on its current intraoral scanning capabilities – which include the recently announced Straumann® Virtuo Vivo™ intraoral scanner – and partnerships to expand its digital business solutions and to unleash the full potential of its fast-growing ClearCorrect business.
The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Straumann, Neodent, Anthogyr, Medentika, ClearCorrect, Dental Wings, and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, biomaterials and digital solutions for use in tooth replacement and restoration or to prevent tooth loss.
Headquartered in Basel, Switzerland, the Group currently employs more than 6000 people worldwide and its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.